During module 1, the main objective was to learn an overview of the development of antibody drugs . The instructor asked the students about biopharmaceutics and the challenges and formulation strategies associated with developing these drugs. From the lecture, the students learned that biopharmaceuticals are drugs made from living cells and organisms, the structures of these drugs, especially antibodies, and how they can be used to treat coronaviruses today . They also learned that high concentrations could lead to high viscosities and the downsides of high-viscosity formulations . The students also learned formulation strategies, such as adding excipients to stabilize the biopharmaceuticals. This activity gave students a better understanding of why computational tools are helpful for antibody drug development . The students were also tasked with finding a research paper that detailed biological drugs, their stability issues, and new formulation strategies to tackle biological drug stability.